Tuesday, August 5, 2014

ZMapp against Ebola virus: GMO is action

‪#‎ZMapp‬ is an experimental mixture of three humanized monoclonal antibodies for immunological protection against the ‪#‎Ebola‬ virus, and manufactured in the Nicotiana plant (Here is ‪#‎GMO‬ in Action). On 4 August 2014 the drug was first tested on humans. It was administered to two Americans who had been infected with Ebola. Both people appeared to have had positive results

No comments:

Post a Comment